Literature DB >> 9733864

The RNA polymerase of influenza virus, bound to the 5' end of virion RNA, acts in cis to polyadenylate mRNA.

L L Poon1, D C Pritlove, J Sharps, G G Brownlee.   

Abstract

We previously demonstrated, by limited mutagenesis, that conserved sequence elements within the 5' end of influenza virus virion RNA (vRNA) are required for the polyadenylation of mRNA in vitro. To further characterize the nucleotide residues at the 5' end of vRNA which might be involved in polyadenylation, a complete set of short and long model vRNA-like templates with mutations at nucleotides 1' to 13' (prime notation denotes numbering from the 5' end) of vRNA were synthesized and transcribed in vitro. The products were assayed for mRNA production with both reverse transcription-PCR and [alpha-32P]ATP incorporation assays. Results from these independent assays showed that vRNA templates with point mutations at positions 2', 3', 7' to 9', and 11' to 13' synthesized polyadenylated transcripts inefficiently compared with those with mutations at positions 1', 4' to 6', and 10'. Positions 2', 3', 7' to 9', and 11' are known to be involved in RNA polymerase binding. Furthermore, residues at positions 11' to 13' are known to be involved in base pairing between the 3' and 5' ends of vRNA. These findings demonstrate that the RNA polymerase has to bind to the 5' end of the template vRNA, which must then interact with the 3' end of the same template for polyadenylation to occur. These results support a model in which a cis-acting RNA polymerase is required for the polyadenylation of influenza virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733864      PMCID: PMC110172     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences.

Authors:  D C Pritlove; L L Poon; E Fodor; J Sharps; G G Brownlee
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle.

Authors:  M T Hsu; J D Parvin; S Gupta; M Krystal; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

Authors:  A R Beaton; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  The genes of influenza virus.

Authors:  P Palese
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

5.  Polyadenylation sites for influenza virus mRNA.

Authors:  J S Robertson; M Schubert; R A Lazzarini
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

7.  RNA polymerase of influenza virus: role of NP in RNA chain elongation.

Authors:  A Honda; K Uéda; K Nagata; A Ishihama
Journal:  J Biochem       Date:  1988-12       Impact factor: 3.387

8.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

9.  Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer.

Authors:  G I Shapiro; R M Krug
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription.

Authors:  S J Plotch; M Bouloy; I Ulmanen; R M Krug
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

View more
  28 in total

1.  Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

Authors:  L L Poon; E Fodor; G G Brownlee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity.

Authors:  M B Leahy; D C Pritlove; L L Poon; G G Brownlee
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template.

Authors:  L L Poon; D C Pritlove; E Fodor; G G Brownlee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication.

Authors:  H Zheng; H A Lee; P Palese; A García-Sastre
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Definition of the minimal viral components required for the initiation of unprimed RNA synthesis by influenza virus RNA polymerase.

Authors:  M T Michael Lee; Konrad Bishop; Liz Medcalf; Debra Elton; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

6.  Structural features of an influenza virus promoter and their implications for viral RNA synthesis.

Authors:  S H Bae; H K Cheong; J H Lee; C Cheong; M Kainosho; B S Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

7.  Hairpin loop structure in the 3' arm of the influenza A virus virion RNA promoter is required for endonuclease activity.

Authors:  M B Leahy; H C Dobbyn; G G Brownlee
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA.

Authors:  M-T Michael Lee; Klaus Klumpp; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

9.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

10.  A small-RNA enhancer of viral polymerase activity.

Authors:  Jasmine T Perez; Ivan Zlatev; Shilpa Aggarwal; Sailakshmi Subramanian; Ravi Sachidanandam; Baek Kim; Muthiah Manoharan; Benjamin R tenOever
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.